Cardiology
RSSArticles
-
Edoxaban Tablets (Savaysa™)
The third oral factor Xa inhibitor has been approved by the FDA. Edoxaban is the fourth target-specific oral anticoagulant (TSOA) to enter the market following dabigatran (Pradaxa), rivaroxaban (Xarelto), and apixaban (Eliquis). Edoxaban is manufactured by Tokyo-based Daiichi Sankyo Company and marketed by Daiichi Sankyo as Savaysa.
-
The Economic Burden of Undiagnosed Pre-diabetes
The economic burden of diagnosed and undiagnosed diabetes, gestational diabetes, and prediabetes has exceeded $322 billion.
-
Treatment of C. Difficile — Follow the Guidelines
ABSTRACT & COMMENTARY: The primary outcome was the occurrence of complications, including relapse within four weeks, surgery, and 30-day mortality.
-
Should Clinicians Discuss Resumption of Sexual Activity Following an Acute MI?
Although the U.S. and European cardiovascular society guidelines recommend that patients be counseled about resuming sexual activity after suffering an acute myocardial infarction (AMI), the actual demographics of sexual education post-myocardial infarction (MI) are unknown.
-
The Whole Is Greater than the Parts: Artemisia Annua and Malaria
Whole plant Artemisia annua more adequately treated one species of the malaria parasite infection in mice.
-
Can Answering a Phone Call Give You Cancer?
In the past decade, cellular phone usage has grown exponentially worldwide, and this use is prevalent in all age groups, including children.
-
Clinical Practice Guidelines for Platelet Transfusion
The American Association of Blood Banks has six recommendations of varying strengths based on the availability of quality evidence.
-
Calcium & Vitamin D Supplementation in Postmenopausal Women
As a significant number of postmenopausal women supplement calcium and vitamin D for bone health, the possibility of over-supplementation is a concern.
-
Benefits of NIV in COPD Supported in Routine Clinical Practice
In a large cohort study, COPD patients managed with noninvasive ventilation had lower inpatient mortality compared to those managed with invasive ventilation.
-
Multicenter QI Project Results in a 23% Reduction in Medical Errors
Implementation of a quality improvement project focused on handoffs reduced medical errors by 23% and preventable adverse events by 30%.